Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subject: PDT

Canadian Telemedicine Provider, Wello, Launches COVID-19 Return to Workplace Platform for Employers


Daily risk screening protocol, integrated clinical support and data management capabilities prioritize safety when transitioning employees back into public spaces.

TORONTO, July 13, 2020 /CNW/ - As the Canadian economy continues reopening amidst COVID-19, businesses face many new challenges and considerations in safely welcoming their employees back to their physical workplace. Many employees also have concerns about returning to their workplaces while keeping themselves, their families, and their coworkers safe and healthy.  

In response to client requests for expanded support, Canadian telemedicine provider, Wello, has developed an integrated self-screening & reporting protocol to help manage the risk of bringing COVID-19 into the workplace. Return to Workplace is an online tool that provides companies with accurate, real?time data on the eligibility of their workforce to return to the physical workplace safely. While businesses are not able to fully mitigate the risk of COVID-19 in workplaces, business leaders who require employees to be physically present are given confidence that employees are being supported and directed in taking the necessary steps to provide a protected space.

In alignment with all Canadian provincial and territorial public health guidelines, employees answer a three?part questionnaire in the tool to determine any presence of health risk. If an employee is not eligible to return, they are provided with access to clinical guidance on appropriate next steps and offered the necessary follow-up support to navigate what may feel like a daunting process.

"Businesses can play a role in reducing the spread of COVID-19 by conducting daily fit-for-work screening of employees before entering their physical workplaces. This simple strategy can make a difference and give employees and customers reassurance and confidence that their health and safety is valued and protected," said Dr. Wendy Smeltzer, National Medical Director, Wello.

As we all remain focused on minimizing the spread of the coronavirus, diligent screening, risk management and mental well-being are top priorities. The Return to Workplace platform offers important resources for both employers and employees so that everyone can feel safer and more secure when they must be in a physical work environment. The new platform is now available to all Canadian employers. For more information please visit, https://wello.ca/return-to-the-workplace or contact Randy Wetmore [email protected].

ABOUT WELLO
Wello is a leading Canadian provider of anytime, anywhere virtual healthcare services. Wello healthcare services are available through phone and video visits as well as secure webchat. Backed by a 41?year history of providing high?quality healthcare through its parent company, INLIV, Wello can be offered as part of a company's health benefits for its employees.

SOURCE Wello


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: